Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chao

Showing results (691-700 of 763) with videos related to

Pageof 77
Sort By:
Bone Marrow Transplantation|July 7, 2020
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantationKo K Maung, Benny J Chen, Ian Barak, et al.
Brain Research|April 23, 2003
Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaineM-C Peakman, C Colby, L I Perrotti, et al.
Bone Marrow Transplantation|January 22, 2013
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentJ Kanda, L Kaynar, Y Kanda, et al.
Plos Genetics|May 12, 2018
Population-specific genetic modification of Huntington's disease in VenezuelaMichael J Chao, Kyung-Hee Kim, Jun Wan Shin, et al.
American Journal of Human Genetics|June 27, 2020
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsKyung-Hee Kim, Eun Pyo Hong, Jun Wan Shin, et al.
Journal of Medicinal Chemistry|August 6, 2010
Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitorsWei Meng, Robert P Brigance, Hannguang J Chao, et al.
Blood|April 22, 2004
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphomaDavid A Rizzieri, Gamal Akabani, Michael R Zalutsky, et al.
The Journal of Family Practice|May 23, 1998
Illuminating the 'black box'. A description of 4454 patient visits to 138 family physiciansK C Stange, S J Zyzanski, C R Jaén, et al.
Blood|February 18, 2014
Increased BCR responsiveness in B cells from patients with chronic GVHDJessica L Allen, Prasanthi V Tata, Matthew S Fore, et al.
Cancer Investigation|June 5, 2010
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapyChristopher A Crout, Liang-Piu Koh, Jon P Gockerman, et al.
Pageof 77

Showing results (691-700 of 763) with videos related to

Sort By:
Pageof 77
Bone Marrow Transplantation|July 7, 2020
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantationKo K Maung, Benny J Chen, Ian Barak, et al.
Brain Research|April 23, 2003
Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaineM-C Peakman, C Colby, L I Perrotti, et al.
Bone Marrow Transplantation|January 22, 2013
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentJ Kanda, L Kaynar, Y Kanda, et al.
Plos Genetics|May 12, 2018
Population-specific genetic modification of Huntington's disease in VenezuelaMichael J Chao, Kyung-Hee Kim, Jun Wan Shin, et al.
American Journal of Human Genetics|June 27, 2020
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsKyung-Hee Kim, Eun Pyo Hong, Jun Wan Shin, et al.
Journal of Medicinal Chemistry|August 6, 2010
Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitorsWei Meng, Robert P Brigance, Hannguang J Chao, et al.
Blood|April 22, 2004
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphomaDavid A Rizzieri, Gamal Akabani, Michael R Zalutsky, et al.
The Journal of Family Practice|May 23, 1998
Illuminating the 'black box'. A description of 4454 patient visits to 138 family physiciansK C Stange, S J Zyzanski, C R Jaén, et al.
Blood|February 18, 2014
Increased BCR responsiveness in B cells from patients with chronic GVHDJessica L Allen, Prasanthi V Tata, Matthew S Fore, et al.
Cancer Investigation|June 5, 2010
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapyChristopher A Crout, Liang-Piu Koh, Jon P Gockerman, et al.
Pageof 77